Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Beta Bionics, Inc. (BBNX : NSDQ)

• Company Description    Beta Bionics Inc. is a commercial-stage medical device company engaged in the design, development and commercialization of solutions. Beta Bionics Inc. is based in IRVINE, Calif. Number of Employees: 294

• Price / Volume Information    Yesterday's Closing Price: $26.41 Daily Weekly Monthly 20 Day Moving Average: 643,920 shares Shares Outstanding: 43.47 (millions) Market Capitalization: $1,148.04 (millions) Beta: 52 Week High: $26.66 52 Week Low: $8.89 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 58.05% 55.27% 12 Week 48.54% 34.92% Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 11 HUGHES - IRVINE,CA 92618 USA ph: 949-427-7785 fax: - ir@betabionics.com http://www.betabionics.com

• General Corporate Information    Officers Sean Saint - Chief Executive Officer;President and Director Adam Lezack - Chairperson of the Board of Directors Stephen Feider - Chief Financial Officer Sean Carney - Director Dan Dearen - Director Peer Information Beta Bionics, Inc. (ABMD) Beta Bionics, Inc. (DMDS) Beta Bionics, Inc. (CPWY.) Beta Bionics, Inc. (EQUR) Beta Bionics, Inc. (ECIA) Beta Bionics, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 08659B102 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/04/25 Share - Related Items Shares Outstanding: 43.47 Most Recent Split Date: (:1) Beta: Market Capitalization: $1,148.04 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.46 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.75 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/04/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.81 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: 25.00% Sales Growth vs. Year Ago Period: 54.45% vs. Previous Quarter: 31.74% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - 14.68 03/31/25 - 15.88 12/31/24 - 6.29 Quick Ratio 06/30/25 - 13.79 03/31/25 - 14.93 12/31/24 - 5.66 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -84.08 Book Value 06/30/25 - 6.94 03/31/25 - 7.24 12/31/24 - -5.72 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - 6.58 Debt-to-Equity 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - - Debt-to-Capital 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - -

Powered by Zacks Investment Research ©